WO2002022825A3 - Das c. albicans tec1 gen (catec1) und das kodierte tec1p protein - Google Patents
Das c. albicans tec1 gen (catec1) und das kodierte tec1p protein Download PDFInfo
- Publication number
- WO2002022825A3 WO2002022825A3 PCT/EP2001/010596 EP0110596W WO0222825A3 WO 2002022825 A3 WO2002022825 A3 WO 2002022825A3 EP 0110596 W EP0110596 W EP 0110596W WO 0222825 A3 WO0222825 A3 WO 0222825A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- proteins
- catec1
- albicans
- tec1p
- tec1
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 7
- 102000004169 proteins and genes Human genes 0.000 title abstract 6
- 241000222122 Candida albicans Species 0.000 title abstract 2
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 3
- 230000002538 fungal effect Effects 0.000 abstract 2
- 239000003112 inhibitor Substances 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 230000001717 pathogenic effect Effects 0.000 abstract 2
- 239000013598 vector Substances 0.000 abstract 2
- 230000001018 virulence Effects 0.000 abstract 2
- 206010007134 Candida infections Diseases 0.000 abstract 1
- 108091023040 Transcription factor Proteins 0.000 abstract 1
- 102000040945 Transcription factor Human genes 0.000 abstract 1
- 229940095731 candida albicans Drugs 0.000 abstract 1
- 201000003984 candidiasis Diseases 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
- C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
- C07K14/40—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Candida
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002218175A AU2002218175A1 (en) | 2000-09-13 | 2001-09-13 | The c. albicans tec1 gene (catec1) and the coded tec1p protein |
EP01984654A EP1319075A2 (de) | 2000-09-13 | 2001-09-13 | Das c. albicans tec1 gen (catec1) und das kodierte tec1p protein |
US10/380,334 US20040044193A1 (en) | 2000-09-13 | 2001-09-13 | C. albicans tec1 gene (catec1) and the coded tecip protein |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23093600P | 2000-09-13 | 2000-09-13 | |
US60/230,936 | 2000-09-13 | ||
DE10045123A DE10045123B8 (de) | 2000-09-13 | 2000-09-13 | Das C. albicans TEC1 GEN(CaTEC1) und das kodierte Tec1p Protein |
DE10045123.3 | 2000-09-13 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2002022825A2 WO2002022825A2 (de) | 2002-03-21 |
WO2002022825A9 WO2002022825A9 (de) | 2002-09-19 |
WO2002022825A3 true WO2002022825A3 (de) | 2002-12-19 |
Family
ID=26007032
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2001/010596 WO2002022825A2 (de) | 2000-09-13 | 2001-09-13 | Das c. albicans tec1 gen (catec1) und das kodierte tec1p protein |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1319075A2 (de) |
AU (1) | AU2002218175A1 (de) |
WO (1) | WO2002022825A2 (de) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000028037A1 (fr) * | 1998-11-10 | 2000-05-18 | Aventis Pharma S.A. | GENE tfIIIA DE CANDIDA ALBICANS (CatfIIIA) ET LA PROTEINE CODEE CATFIIIA |
-
2001
- 2001-09-13 AU AU2002218175A patent/AU2002218175A1/en not_active Abandoned
- 2001-09-13 EP EP01984654A patent/EP1319075A2/de not_active Withdrawn
- 2001-09-13 WO PCT/EP2001/010596 patent/WO2002022825A2/de not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000028037A1 (fr) * | 1998-11-10 | 2000-05-18 | Aventis Pharma S.A. | GENE tfIIIA DE CANDIDA ALBICANS (CatfIIIA) ET LA PROTEINE CODEE CATFIIIA |
Non-Patent Citations (2)
Title |
---|
LALOUX I ET AL: "TEC1 A GENE INVOLVED IN THE ACTIVATION OF TY1 AND TY1-MEDIATED GENE EXPRESSION IN SACCHAROMYCES-CEREVISIAE CLONING AND MOLECULAR ANALYSIS", MOLECULAR AND CELLULAR BIOLOGY, vol. 10, no. 7, 1990, pages 3541 - 3550, XP002207862, ISSN: 0270-7306 * |
SCHWEIZER ANJA ET AL: "The TEA/ATTS transcription factor CaTec1p regulates hyphal development and virulence in Candida albicans.", MOLECULAR MICROBIOLOGY, vol. 38, no. 3, November 2000 (2000-11-01), pages 435 - 445, XP002207861, ISSN: 0950-382X * |
Also Published As
Publication number | Publication date |
---|---|
AU2002218175A1 (en) | 2002-03-26 |
EP1319075A2 (de) | 2003-06-18 |
WO2002022825A2 (de) | 2002-03-21 |
WO2002022825A9 (de) | 2002-09-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2000003685A3 (en) | Nitrilase homologs | |
WO1998014596A3 (en) | Disease associated protein tyrosine phosphatases | |
WO2002050277A3 (en) | Protein and nucleic acids encoding same | |
DE69840333D1 (de) | 2-m übergang des zellzyklus | |
EP0826774A3 (de) | Fab I Enoyl-ACP-Reduktase aus Staphylokokken | |
WO2004087766A3 (en) | Peptabody for cancer treatment | |
WO2003054012A3 (en) | Leptin proteins | |
WO2001046225A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
WO2002022825A3 (de) | Das c. albicans tec1 gen (catec1) und das kodierte tec1p protein | |
WO2003048317A3 (en) | Antibodies to magmas and uses thereof | |
WO2001057069A3 (en) | Targeting peptides | |
WO2004112575A3 (en) | Gene amplification and overexpression in cancer | |
EP0845535A3 (de) | Leader peptidase (lep) aus Streptococcus | |
WO2005023979A3 (en) | Isolated s. mansoni nucleic acid molecules and uses thereof | |
WO1997040134A3 (en) | Human dnase ii | |
WO2005049793A3 (en) | Methods and compositions for combinatorial approaches to cancer gene therapy | |
WO2006020824A3 (en) | Diagnosis and treatment of kawasaki disease and coronavirus infection | |
AU2001270518A1 (en) | Hypha-specific factors from candida albicans | |
FR2813606B1 (fr) | Proteine bard1 tronquee, et ses applications diagnostiques et therapeutiques | |
WO2000026237A3 (en) | Chlamydia 98kd putative outer membrane protein and corresponding dna fragments and uses thereof | |
WO2004091479A3 (en) | Gene amplification and overexpression in cancer | |
WO2001049839A3 (en) | Method for expressing gene and use thereof | |
WO2002050116A3 (en) | Adhesion molecule protein | |
WO2002062845A3 (en) | Adhesion molecules | |
AU2015201737B2 (en) | Identification of tumour-associated cell surface antigens for diagnosis and therapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: C2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: C2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
COP | Corrected version of pamphlet |
Free format text: PAGE 13/13, DRAWINGS, REPLACED BY A NEW PAGE 13/13; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001984654 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2001984654 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10380334 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2001984654 Country of ref document: EP |